SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-24-000052
Filing Date
2024-05-09
Accepted
2024-05-09 16:11:55
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20240331.htm   iXBRL 10-Q 811251
2 EX-10.1 exhibit101-viraniadvisorya.htm EX-10.1 67701
3 EX-10.2 exhibit102-viranitransitio.htm EX-10.2 127968
4 EX-31.1 exhibit311-q0124.htm EX-31.1 7380
5 EX-31.2 exhibit312-q0124.htm EX-31.2 7367
6 EX-32.1 exhibit321-q0124.htm EX-32.1 3274
12 rxrx-20240331_g1.jpg GRAPHIC 97496
13 rxrx-20240331_g2.jpg GRAPHIC 226167
  Complete submission text file 0001601830-24-000052.txt   6660587

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20240331.xsd EX-101.SCH 44726
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20240331_cal.xml EX-101.CAL 77980
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20240331_def.xml EX-101.DEF 233939
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20240331_lab.xml EX-101.LAB 605525
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20240331_pre.xml EX-101.PRE 415793
81 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20240331_htm.xml XML 642449
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 24930724
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)